The Transformative Potential of AI in Drug Discovery
Presented by SGInnovate
Artificial Intelligence (AI) has been making inroads in drug discovery for most of the last decade. AI offers significant technological advances that may represent a paradigm shift in drug discovery and, ultimately, clinical development.
Given the transformative potential of AI, companies need to plan for a future in which AI is routinely used in drug discovery. While it may be tempting to think that AI can be delivered through a new tool or a single team, this is rarely the case. Instead, achieving total value from AI requires a transformation of the discovery process.
In this session, our panel of thought leaders will be sharing their insights on the critical focus and priorities in delivering the promise of AI. This includes, among others, the necessary investments in data and technology, the skillsets and talent required internally, and the external partnerships that will help them expedite the integration of AI into their processes.
Date: 13 October 2022, Thursday
Time: 11:00am – 12:00pm (Singapore Time / UTC +8)
11:00am – 11:05am: Introduction and Welcome
11:05am – 12:00pm: Panel Discussion and Q&A on The Transformative Potential of AI in Drug Discovery
Topics: MedTech / HealthTech / BioTech
Industry: Health and BioMedical Sciences